Apellis Pharmaceuticals (APLS) Earnings Date, Estimates & Call Transcripts

→ Special FREE offer on stock hotsheets (From DTI) (Ad)

Free apls Stock Alerts

$47.51

-0.52 (-1.08%)

(As of 04/18/2024 ET)

Compare

Upcoming Earnings Date: May. 2Estimated
Actual EPS (Feb. 27): -$0.73
Consensus EPS (Feb. 27): -$0.73

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

APLS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

APLS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Insiders Exposed

This consistently signaled gains of 453%... 610%... and even 1036%...

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

Apellis Pharmaceuticals Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	3	($0.88)	($0.56)	($0.69)
Q2 2024	3	($0.60)	($0.41)	($0.50)
Q3 2024	3	($0.49)	($0.29)	($0.37)
Q4 2024	3	($0.26)	($0.15)	($0.19)
FY 2024	12	($2.23)	($1.41)	($1.75)
Q1 2025	1	$0.06	$0.06	$0.06
Q2 2025	1	$0.18	$0.18	$0.18
Q3 2025	1	$0.30	$0.30	$0.30
Q4 2025	1	$0.55	$0.55	$0.55
FY 2025	4	$1.09	$1.09	$1.09

APLS Earnings Date and Information

Apellis Pharmaceuticals last posted its earnings data on February 27th, 2024. The reported ($0.73) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.73). The company had revenue of $146.38 million for the quarter, compared to analysts' expectations of $143.34 million. Its quarterly revenue was up 545.9% compared to the same quarter last year. Apellis Pharmaceuticals has generated ($4.48) earnings per share over the last year (($4.48) diluted earnings per share). Earnings for Apellis Pharmaceuticals are expected to grow in the coming year, from ($1.33) to $1.08 per share. Apellis Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

Apellis Pharmaceuticals Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/2/2024 Estimated)	-	-	-	-	-	-	-
2/27/2024	Q4 2023	($0.73)	($0.73)	-	($0.73)	$143.34 million	$146.38 million
11/1/2023	Q3 2023	($0.88)	($1.17)	($0.29)	($1.17)	$99.05 million	$110.40 million
7/31/2023	Q2 2023	($1.35)	($1.02)	+$0.33	($1.02)	$70.38 million	$95.00 million
5/4/2023	Q1 2023	($1.42)	($1.56)	($0.14)	($1.56)	$26.10 million	$44.80 million
2/21/2023	Q4 2022	($1.45)	($1.50)	($0.05)	($1.50)	$24.44 million	$22.70 million
11/7/2022	Q3 2022	($1.48)	($1.75)	($0.27)	($1.75)	$19.82 million	$22.06 million
Get the Latest News and Ratings for APLS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
8/8/2022	Q2 2022	($1.43)	($1.46)	($0.03)	($1.46)	$17.16 million	$16.32 million
5/4/2022	Q1 2022	($1.36)	($1.42)	($0.06)	($1.42)	$12.81 million	$14.38 million
2/28/2022	Q4 2021	($1.32)	($1.61)	($0.29)	($1.61)	$8.52 million	$60.29 million
11/8/2021	Q3 2021	($1.73)	($2.28)	($0.55)	($2.28)	$2.32 million	$5.65 million
8/8/2021	Q2 2021	($1.70)	($2.72)	($1.02)	($2.72)	$2.26 million	$0.62 million
4/27/2021	Q1 2021	($1.69)	($2.32)	($0.63)	($2.32)	-	-

Apellis Pharmaceuticals Earnings - Frequently Asked Questions

When is Apellis Pharmaceuticals's earnings date?: Apellis Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on APLS's earnings history.
Did Apellis Pharmaceuticals beat their earnings estimates last quarter?: In the previous quarter, Apellis Pharmaceuticals (NASDAQ:APLS) reported ($0.73) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.73). Learn more on analysts' earnings estimate vs. APLS's actual earnings.
How can I listen to Apellis Pharmaceuticals's earnings conference call?: The conference call for Apellis Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Apellis Pharmaceuticals's conference call transcript?: The conference call transcript for Apellis Pharmaceuticals's latest earnings report can be read online. Read Transcript
How much revenue does Apellis Pharmaceuticals generate each year?: Apellis Pharmaceuticals (NASDAQ:APLS) has a recorded annual revenue of $396.59 million.
How much profit does Apellis Pharmaceuticals generate each year?: Apellis Pharmaceuticals (NASDAQ:APLS) has a recorded net income of -$528.63 million. APLS has generated -$4.48 earnings per share over the last four quarters.
What is Apellis Pharmaceuticals's EPS forecast for next year?: Apellis Pharmaceuticals's earnings are expected to grow from ($1.33) per share to $1.08 per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:APLS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Apellis Pharmaceuticals (APLS) Earnings Date, Estimates & Call Transcripts

APLS Earnings Estimates and Actuals by Quarter

APLS Estimated and Actual Revenue by Quarter

Apellis Pharmaceuticals Analyst EPS Estimates

APLS Earnings Date and Information

Apellis Pharmaceuticals Earnings History by Quarter

Apellis Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Apellis Pharmaceuticals (APLS) Earnings Date, Estimates & Call Transcripts

Earnings Summary

APLS Earnings Estimates and Actuals by Quarter

APLS Estimated and Actual Revenue by Quarter

Apellis Pharmaceuticals Analyst EPS Estimates

APLS Earnings Date and Information

Apellis Pharmaceuticals Earnings History by Quarter

Apellis Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat